The maintained guidance and continued deleveraging provide a floor for the stock, but the organic revenue decline and negative free cash flow limit upside. Monitor the pace of refranchising deals and U.S. organic revenue trajectory for signs of sustainable growth; the next catalyst is the Q3 print showing whether APD growth can offset door closures.
Price Chart
Executive Summary
Krispy Kreme reported Q2 2026 GAAP net revenue of $331.0M, down 12.8% YoY primarily due to refranchising and strategic door closures, with an organic revenue decline of 0.3%. Adjusted EBITDA rose 43.2% to $28.8M, and the company maintained its full-year 2026 guidance for net revenue of $1.25B-$1.35B and Adjusted EBITDA of $140M-$150M, signaling continued turnaround progress despite top-line contraction from the business model shift.
Key Financial Metrics
Key Facts
- Net revenue declined 12.8% YoY to $331.0M, driven by refranchising and closure of ~2,400 McDonald's USA doors.
- Organic revenue declined 0.3% YoY; excluding McDonald's impact, systemwide sales grew 2.6% in constant currency.
- Adjusted EBITDA increased 43.2% to $28.8M, with margin expanding 340 bps to 8.7%.
- GAAP net loss improved to $19.8M from $441.1M in Q2 2025 (which included a $356M goodwill impairment).
- Net leverage ratio reduced to 5.4x from 6.7x at year-end 2025, a 1.3x reduction.
- Full-year 2026 guidance maintained: net revenue $1.25B-$1.35B, Adjusted EBITDA $140M-$150M, net leverage below 5.5x.
- U.S. segment organic revenue grew 0.1% YoY (or 4.4% excluding McDonald's), with APD up 33.2% to ~$697.
- International segment organic revenue declined 5.1%, with Adjusted EBITDA down 22.2% due to Japan refranchising and weakness in UK/Australia.
- Market Development segment organic revenue grew 14.4%, driven by royalty growth in Middle East, Japan, and Brazil.
- Year-to-date free cash flow was -$6.1M, improving $101.3M vs H1 2025.
- Approximately 42% of systemwide sales now from franchisees, targeting ~50% by fiscal 2027.
Financial Impact
Revenue decline of $48.8M (-12.8%) YoY; Adjusted EBITDA improvement of $8.7M (+43.2%); net debt reduced by $92.7M vs year-end 2025.
Risk Factors
- Organic revenue still declining (-0.3%), indicating underlying business contraction beyond refranchising.
- International segment weakness (UK, Australia) may persist and offset U.S. and Market Development gains.
- Negative free cash flow (-$6.1M YTD) and high net leverage (5.4x) limit financial flexibility.
- Execution risk on additional refranchising deals needed to reach ~50% franchise mix by FY2027.
Market Snapshot
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001857154-26-000044 |
| Document: dnut-20260806.htm | 0001857154-26-000044 |
| Document: 0001857154-26-000044-index-headers.html | 0001857154-26-000044 |
| Document: 0001857154-26-000044-index.html | 0001857154-26-000044 |
| Document: 0001857154-26-000044.txt | 0001857154-26-000044 |
| 8-K Data (Synthetic) | 0001857154-26-000044 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 6, 2026 11w ago | 8-K | $3.23 $3.34 | ▲ +3.41% | ▲ +2.81% | $2.91 (−9.91%) |
Jun 12, 2026 19w ago | 3/A | $3.99 $3.47 | ▼ −13.03% | ▼ −12.28% | $2.91 (−27.07%) |
Jun 11, 2026 19w ago | Institutional Cluster | $4.20 $3.42 | ▼ −18.57% | ▼ −20.46% | $2.91 (−30.71%) |
May 7, 2026 24w ago | DEFA14A | $3.64 $3.30 | ▼ −9.34% | ▼ −12.48% | $2.91 (−20.05%) |
May 7, 2026 24w ago | 8-K | $3.64 $3.30 | ▼ −9.34% | ▼ −12.48% | $2.91 (−20.05%) |
Apr 10, 2026 28w ago | 3 | $3.31 $3.38 | ▲ +2.11% | ▼ −5.61% | $2.91 (−12.08%) |
Feb 26, 2026 34w ago | 8-K | $3.82 $3.42 | ▼ −10.47% | ▼ −4.07% | $2.91 (−23.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers